Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1432]

AACR: New antibody-drug conjugate shows early promise against all forms of melanoma

AACR: New antibody-drug conjugate shows early promise against all forms of melanoma

AACR: Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

AACR: Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Largest ever melanoma study demonstrates tolerability and efficacy of vemurafenib in most aggressive form of skin cancer

Largest ever melanoma study demonstrates tolerability and efficacy of vemurafenib in most aggressive form of skin...

Genetic mutations warn of skin cancer risk: New high-risk cancer causing mutation identified for melanoma development

Genetic mutations warn of skin cancer risk: New high-risk cancer causing mutation identified for melanoma...

Study unravels mechanism for regaining treatment sensitivity

Study unravels mechanism for regaining treatment sensitivity

Young nonmelanoma skin cancer survivors more likely to get other cancers later

Young nonmelanoma skin cancer survivors more likely to get other cancers later

Skin cancer risk may have driven evolution of black skin

Skin cancer risk may have driven evolution of black skin

New melanoma diagnosis and prognosis method patented

New melanoma diagnosis and prognosis method patented

Gene blocks body's ability to fight skin cancer

Gene blocks body's ability to fight skin cancer

130,000 people in the UK diagnosed at 65 or over survive cancer for at least a decade

130,000 people in the UK diagnosed at 65 or over survive cancer for at least a decade

More from ecancer